Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS
Content archived on 2024-05-28

Metagenome and Bariatric Surgery - New Avenues to Treat Metabolic Disease

Objective

Obesity and associated metabolic diseases such as type 2 diabetes are increasing worldwide and are the result of complex gene-environment interactions. Recent studies indicate that socio-demographic and environmental factors are more important for disease development than genetics, and we and others have demonstrated that the gut microbiota can be considered an environmental factor that contributes to obesity. Effective treatment for obesity remains a challenge and bariatric surgery is the only available therapy that is proven to maintain weight loss. Intriguingly, bariatric surgery also improves glucose metabolism, but the underlying molecular mechanisms for this beneficial effect are unclear. An altered gut microbiota has been linked to metabolic diseases and pilot studies indicate that the gut microbiota is also altered upon bariatric surgery; these findings suggest that some of the improved metabolic features following bariatric surgery may be mediated by altered composition of the gut microbiota. The overall goal of this proposal is to integrate clinical research with mechanistic studies in mice to determine if and how the gut microbiota mediates the beneficial effects of bariatric surgery. We will define how bariatric surgery alters the gut metagenome in humans, both at a species and at a functional level. By transferring the fecal microbiota from these patients before and after surgery to germ-free mice, we will determine if an altered gut microbiota directly modulates host metabolism. Finally, we will establish surgical methods in germ-free mice to directly test whether the beneficial effects observed following surgery require a microbiota. Increased understanding of these mechanisms may provide the basis for non-surgical treatments based on supplementation of novel probiotics to treat metabolic diseases. Follow-up work in larger clinical cohorts may also indicate how patients can be stratified to determine who would benefit the most from bariatric surgery.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

ERC-2013-CoG
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

ERC-CG - ERC Consolidator Grants

Host institution

GOETEBORGS UNIVERSITET
EU contribution
€ 2 000 000,00
Address
VASAPARKEN
405 30 Goeteborg
Sweden

See on map

Region
Södra Sverige Västsverige Västra Götalands län
Activity type
Higher or Secondary Education Establishments
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Beneficiaries (1)

My booklet 0 0